S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Modern Day Options Trading For Beginners! (Ad)pixel
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Modern Day Options Trading For Beginners! (Ad)pixel
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Bank Accounts: Frozen! (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
NASDAQ:STAA

STAAR Surgical - STAA Price Target & Analyst Ratings

$63.51
-0.11 (-0.17%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$62.44
$64.70
50-Day Range
$55.39
$79.34
52-Week Range
$46.35
$112.27
Volume
368,765 shs
Average Volume
789,924 shs
Market Capitalization
$3.06 billion
P/E Ratio
81.42
Dividend Yield
N/A
Price Target
$82.20

STAAR Surgical Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 10 Analyst Ratings

Consensus Analyst Price Target

$82.20
29.43% Upside
High Prediction$125.00
Average Prediction$82.20
Low Prediction$60.00
TypeCurrent
3/28/22 to 3/28/23
1 Month Ago
2/26/22 to 2/26/23
3 Months Ago
12/28/21 to 12/28/22
1 Year Ago
3/28/21 to 3/28/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
8 Buy rating(s)
9 Buy rating(s)
3 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$82.20$82.20$87.70$110.50
Predicted Upside29.43% Upside23.03% Upside32.54% Upside22.69% Upside
Get STAAR Surgical Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

STAA Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

STAA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

STAAR Surgical Stock vs. The Competition

TypeSTAAR SurgicalMedical CompaniesS&P 500
Consensus Rating Score
2.80
2.64
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside29.43% Upside1,993.26% Upside22.47% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
2/22/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight$85.00+25.87%
2/22/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$83.00 ➝ $78.00+15.50%
2/6/2023BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
2/1/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$78.00 ➝ $75.00+6.31%
1/30/2023Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$79.00 ➝ $80.00+15.67%
12/7/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$60.00-1.94%
11/7/2022Sidoti
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Buy
10/14/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$97.00 ➝ $88.00+22.22%
10/12/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$85.00+20.93%
8/11/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$165.00 ➝ $125.00+42.96%
7/8/2021Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageMarket Perform$150.00+4.58%
(Data available from 3/28/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












STAA Price Target - Frequently Asked Questions

What is STAAR Surgical's consensus rating and price target?

According to the issued ratings of 10 analysts in the last year, the consensus rating for STAAR Surgical stock is Moderate Buy based on the current 2 hold ratings and 8 buy ratings for STAA. The average twelve-month price prediction for STAAR Surgical is $82.20 with a high price target of $125.00 and a low price target of $60.00. Learn more on STAA's analyst rating history.

Do Wall Street analysts like STAAR Surgical more than its competitors?

Analysts like STAAR Surgical more than other Medical companies. The consensus rating for STAAR Surgical is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how STAA compares to other companies.

Is STAAR Surgical being downgraded by Wall Street analysts?

Over the previous 90 days, STAAR Surgical's stock had 1 downgrade by analysts.

Does STAAR Surgical's stock price have much upside?

According to analysts, STAAR Surgical's stock has a predicted upside of 23.03% based on their 12-month price targets.

What analysts cover STAAR Surgical?

STAAR Surgical has been rated by Benchmark, BTIG Research, Canaccord Genuity Group, Needham & Company LLC, and Stephens in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:STAA) was last updated on 3/28/2023 by MarketBeat.com Staff